poncirin and Diabetes-Mellitus--Type-2

poncirin has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for poncirin and Diabetes-Mellitus--Type-2

Article	Year
Poncirin, an orally active flavonoid exerts antidiabetic complications and improves glucose uptake activating PI3K/Akt signaling pathway in insulin resistant C2C12 cells with anti-glycation capacities. Bioorganic chemistry, 2020, Volume: 102 Topics: alpha-Glucosidases; Animals; Diabetes Mellitus, Type 2; Flavonoids; Glucose; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction	2020

Article

Year

Poncirin, an orally active flavonoid exerts antidiabetic complications and improves glucose uptake activating PI3K/Akt signaling pathway in insulin resistant C2C12 cells with anti-glycation capacities.

Bioorganic chemistry, 2020, Volume: 102

Topics: alpha-Glucosidases; Animals; Diabetes Mellitus, Type 2; Flavonoids; Glucose; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2020